LACZI F et al. EFFECTS OF LYSINE-VASOPRESSIN AND 1-DEAMINO-8-D-ARGININE-VASOPRESSIN ON MEMORY IN HEALTHY-INDIVIDUALS AND DIABETES-INSIPIDUS PATIENTS. (1982) PSYCHONEUROENDOCRINOLOGY 0306-4530 7 2-3 185-193,
2423511
Parker Karen J. et al. A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. (2019) SCIENCE TRANSLATIONAL MEDICINE 1946-6234 11 491
Glahn Alexander et al. Alcohol-Induced Changes in Methylation Status of Individual CpG Sites, and Serum Levels of Vasopressin and Atrial Natriuretic Peptide in Alcohol-Dependent Patients during Detoxification Treatment. (2014) EUROPEAN ADDICTION RESEARCH 1022-6877 1421-9891 20 3 143-150
Hillemacher Thomas et al. Appetite- and volume-regulating neuropeptides: Role in treating alcohol dependence. (2010) CURRENT OPINION IN INVESTIGATIONAL DRUGS 1472-4472 2040-3429 11 10 1097-1106
Hillemacher Thomas et al. Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal. (2009) PSYCHONEUROENDOCRINOLOGY 0306-4530 34 4 555-560
Viviani Daniele et al. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. (2008) PROGRESS IN BRAIN RESEARCH 0079-6123 1875-7855 170 Regensburg 207-218
Hillemacher Thomas et al. Recurrent hyponatremia under desmopressin overdosing - is abuse a possible explication?. (2007) AMERICAN JOURNAL OF EMERGENCY MEDICINE 0735-6757 1532-8171 25 2 239-240
Abdollahian E et al. Effects of desmopressin (DDAVP) on memory impairment following electroconvulsive therapy (ECT). (2004) ACTA NEUROPSYCHIATRICA 0924-2708 1601-5215 16 3 130-137
BRUINS J et al. EFFECT OF ACUTE AND CHRONIC TREATMENT WITH DESGLYCINAMIDE-[ARG(8)]VASOPRESSIN IN YOUNG MALE AND FEMALE VOLUNTEERS. (1995) PEPTIDES 0196-9781 1873-5169 16 2 179-186
MCCLELLAND DC. ACHIEVEMENT-MOTIVATION IN RELATION TO ACHIEVEMENT-RELATED RECALL, PERFORMANCE, AND URINE FLOW, A MARKER ASSOCIATED WITH RELEASE OF VASOPRESSIN. (1995) MOTIVATION AND EMOTION 0146-7239 19 1 59-76
BRUINS J et al. EFFECT OF A SINGLE DOSE OF DES-GLYCINAMIDE-[ARG8]VASOPRESSIN OR OXYTOCIN ON COGNITIVE-PROCESSES IN YOUNG HEALTHY-SUBJECTS. (1992) PEPTIDES 0196-9781 1873-5169 13 3 461-468
CARTER JS et al. EFFECTS OF DDAVP ON MOVEMENT PLANNING AND EXECUTION PROCESSES IN THE HEALTHY ELDERLY. (1991) PEPTIDES 0196-9781 1873-5169 12 4 871-876
FEHMWOLFSDORF G et al. BEHAVIORAL-EFFECTS OF NEUROHYPOPHYSEAL PEPTIDES IN HEALTHY-VOLUNTEERS - 10 YEARS OF RESEARCH. (1991) PEPTIDES 0196-9781 1873-5169 12 6 1399-1406
BECKWITH BE et al. THE EFFECTS OF VASOPRESSIN ON MEMORY IN HEALTHY-YOUNG ADULT VOLUNTEERS - THEORETICAL AND METHODOLOGICAL ISSUES. (1990) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 579 215-226
LEGROS JJ et al. VASOPRESSIN AND VASOPRESSIN ANALOGS FOR TREATMENT OF MEMORY DISORDERS IN CLINICAL-PRACTICE. (1988) PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 0278-5846 1878-4216 12 S71-S86
GEENEN V et al. INHIBITORY INFLUENCE OF OXYTOCIN INFUSION ON CONTINGENT NEGATIVE-VARIATION AND SOME MEMORY TASKS IN NORMAL MEN. (1988) PSYCHONEUROENDOCRINOLOGY 0306-4530 13 5 367-375
MILLAR K et al. VASOPRESSIN AND MEMORY - IMPROVEMENT IN NORMAL SHORT-TERM RECALL AND REDUCTION OF ALCOHOL-INDUCED AMNESIA. (1987) PSYCHOLOGICAL MEDICINE 0033-2917 1469-8978 17 2 335-341
HAMBURGERBAR R et al. ANIMAL AND CLINICAL-STUDIES OF VASOPRESSIN EFFECTS ON LEARNING AND MEMORY. (1987) ISRAEL JOURNAL OF MEDICAL SCIENCES 0021-2180 23 1-2 12-18
VANHAAREN F et al. VASOPRESSIN HAS GENERAL RATE-DECREASING EFFECTS ON SCHEDULES MAINTAINING EITHER HIGH OR LOW RESPONSE RATES. (1986) PSYCHOPHARMACOLOGY 0033-3158 1432-2072 89 1 69-72
GREIDANUS TBV et al. VASOPRESSIN AND OXYTOCIN THEIR PRESENCE IN THE CENTRAL-NERVOUS-SYSTEM AND THEIR FUNCTIONAL-SIGNIFICANCE IN BRAIN PROCESSES RELATED TO BEHAVIOR AND MEMORY. (1986) ACTA ENDOCRINOLOGICA 0001-5598 112 85-94
HRUBY VJ. STRUCTURE ACTIVITY OF THE NEUROHYPOPHYSEAL HORMONES AND ANALOGS AND IMPLICATIONS FOR HORMONE RECEPTOR INTERACTIONS. (1986) BIOCHEMICAL ACTIONS OF HORMONES 13 191-241
DURKO I et al. PORPHYRIN SYNTHESIS IN PRIMARY NERVOUS-TISSUE CULTURES FROM 10(-3) M DELTA-AMINOLEVULINIC-ACID IN THE PRESENCE OF MELATONIN AND NEUROPEPTIDES. (1986) NEUROCHEMICAL RESEARCH 0364-3190 1573-6903 11 5 607-615
EISENHOFER G et al. NO IMPROVEMENT IN ETHANOL-INDUCED MEMORY DEFICITS AFTER ADMINISTRATION OF A VASOPRESSIN ANALOG. (1985) LIFE SCIENCES 0024-3205 37 26 2499-2505
GREENBERG D et al. DDAVP AS A POSSIBLE METHOD TO ENHANCE POSITIVE BENEFIT OF BEHAVIOR-THERAPY. (1985) BRITISH JOURNAL OF PSYCHIATRY 0007-1250 1472-1465 147 713-715
STRUPP BJ et al. A MNEMONIC ROLE FOR VASOPRESSIN - THE EVIDENCE FOR AND AGAINST. (1985) NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 0149-7634 1873-7528 9 3 399-411
SIEGFRIED B et al. VASOPRESSIN IMPAIRS OR ENHANCES RETENTION OF LEARNED SUBMISSIVE BEHAVIOR IN MICE DEPENDING ON THE TIME OF APPLICATION. (1984) BEHAVIOURAL BRAIN RESEARCH 0166-4328 1872-7549 11 3 259-269
FEHMWOLFSDORF G et al. HUMAN-MEMORY AND NEUROHYPOPHYSEAL HORMONES - OPPOSITE EFFECTS OF VASOPRESSIN AND OXYTOCIN. (1984) PSYCHONEUROENDOCRINOLOGY 0306-4530 9 3 285-292
SCHERBAUM WA. RECENT DISCOVERIES ON THE RELEASE AND EFFECT OF VASOPRESSIN AND OXYTOCIN. (1983) DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 0012-0472 1439-4413 108 51-5 1970-1975
VALKUSZ Z. DEVELOPMENT OF THE SCHWARTZ-BARTTER SYNDROME AFTER THE ADMINISTRATION OF CHLORPROPAMIDE AND 1-DEAMINO-8-D-ARGININE VASOPRESSIN. (1982) ENDOKRINOLOGIE 0013-7251 79 3 345-348,
2913233
Laczi F et al. EFFECTS OF DESGLYCINAMIDE-ARGININE-VASOPRESSIN (DG-AVP) ON MEMORY PROCESSES IN DIABETES-INSIPIDUS PATIENTS AND NON- DIABETIC SUBJECTS. (1983) ACTA ENDOCRINOLOGICA 0001-5598 102 205-212,
11912
Leng Gareth et al. The vasopressin-memory hypothesis: a citation network analysis of a debate. (2019) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 1455 1 126-140
Wade M et al. Association between the arginine vasopressin receptor 1A (AVPR1A) gene and preschoolers' executive functioning. (2014) BRAIN AND COGNITION 0278-2626 1090-2147 90 116-123
Perras B et al. Verbal memory after three months of intranasal vasopressin in healthy old humans. (1997) PSYCHONEUROENDOCRINOLOGY 0306-4530 22 6 387-396
CRAANEVANHINSBERG WHM et al. IONTOPHORESIS OF A MODEL PEPTIDE ACROSS HUMAN SKIN IN-VITRO - EFFECTS OF IONTOPHORESIS PROTOCOL, PH, AND IONIC-STRENGTH ON PEPTIDE FLUX AND SKIN IMPEDANCE. (1994) PHARMACEUTICAL RESEARCH 0724-8741 1573-904X 11 9 1296-1300
PITMAN RK et al. EFFECTS OF INTRANASAL VASOPRESSIN AND OXYTOCIN ON PHYSIOLOGICAL RESPONDING DURING PERSONAL COMBAT IMAGERY IN VIETNAM VETERANS WITH POSTTRAUMATIC-STRESS-DISORDER. (1993) PSYCHIATRY RESEARCH 0165-1781 48 2 107-117
FEHMWOLFSDORF G et al. BEHAVIORAL-EFFECTS OF NEUROHYPOPHYSEAL PEPTIDES IN HEALTHY-VOLUNTEERS - 10 YEARS OF RESEARCH. (1991) PEPTIDES 0196-9781 1873-5169 12 6 1399-1406
BECKWITH BE et al. THE EFFECTS OF VASOPRESSIN ON MEMORY IN HEALTHY-YOUNG ADULT VOLUNTEERS - THEORETICAL AND METHODOLOGICAL ISSUES. (1990) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 579 215-226
BECKWITH BE et al. DOSE-DEPENDENT EFFECTS OF DDAVP ON MEMORY IN HEALTHY-YOUNG ADULT MALES - A PRELIMINARY-STUDY. (1990) PEPTIDES 0196-9781 1873-5169 11 3 473-476
PIETROWSKY R et al. THE INFLUENCE OF A VASOPRESSIN-ANALOGUE (DGAVP) ON EVENT-RELATED POTENTIALS IN A STIMULUS-MISMATCH PARADIGM. (1989) BIOLOGICAL PSYCHOLOGY 0301-0511 1873-6246 28 3 239-250
VANHOOGDALEM EJ et al. RECTAL ABSORPTION ENHANCEMENT OF CEFOXITIN AND DESGLYCINAMIDE ARGININE VASOPRESSIN BY SODIUM TAURO-24,25-DIHYDROFUSIDATE IN CONSCIOUS RATS. (1989) JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 0022-3565 1521-0103 251 2 741-744
LEGROS JJ et al. VASOPRESSIN AND VASOPRESSIN ANALOGS FOR TREATMENT OF MEMORY DISORDERS IN CLINICAL-PRACTICE. (1988) PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 0278-5846 1878-4216 12 S71-S86
VANBREE JBMM et al. RADIOIMMUNOASSAY OF DESGLYCINAMIDE-ARGININE VASOPRESSIN AND ITS APPLICATION IN A PHARMACOKINETIC STUDY IN THE RAT. (1988) PEPTIDES 0196-9781 1873-5169 9 3 555-559
GEENEN V et al. INHIBITORY INFLUENCE OF OXYTOCIN INFUSION ON CONTINGENT NEGATIVE-VARIATION AND SOME MEMORY TASKS IN NORMAL MEN. (1988) PSYCHONEUROENDOCRINOLOGY 0306-4530 13 5 367-375
MILLAR K et al. VASOPRESSIN AND MEMORY - IMPROVEMENT IN NORMAL SHORT-TERM RECALL AND REDUCTION OF ALCOHOL-INDUCED AMNESIA. (1987) PSYCHOLOGICAL MEDICINE 0033-2917 1469-8978 17 2 335-341
Kastin AJ et al. Possible therapeutic implications of the effects of some peptides on the brain. (1987) PROGRESS IN BRAIN RESEARCH 0079-6123 1875-7855 72 223-234
HAMBURGERBAR R et al. ANIMAL AND CLINICAL-STUDIES OF VASOPRESSIN EFFECTS ON LEARNING AND MEMORY. (1987) ISRAEL JOURNAL OF MEDICAL SCIENCES 0021-2180 23 1-2 12-18
GREIDANUS TBV et al. VASOPRESSIN AND OXYTOCIN THEIR PRESENCE IN THE CENTRAL-NERVOUS-SYSTEM AND THEIR FUNCTIONAL-SIGNIFICANCE IN BRAIN PROCESSES RELATED TO BEHAVIOR AND MEMORY. (1986) ACTA ENDOCRINOLOGICA 0001-5598 112 85-94
HRUBY VJ. STRUCTURE ACTIVITY OF THE NEUROHYPOPHYSEAL HORMONES AND ANALOGS AND IMPLICATIONS FOR HORMONE RECEPTOR INTERACTIONS. (1986) BIOCHEMICAL ACTIONS OF HORMONES 13 191-241
KELESHEVA LF. COMPARISON OF THE EFFECTS OF MICROINJECTIONS OF ANGIOTENSIN-II AND BRADYKININ INTO THE LATERAL VENTRICLES AND THEIR INSTILLATION INTO THE CONJUNCTIVA ON FEEDING-BEHAVIOR OF RATS. (1986) BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE 0007-4888 1573-8221 101 6 792-795
RASKIND MA et al. CEREBROSPINAL-FLUID VASOPRESSIN, OXYTOCIN, SOMATOSTATIN, AND BETA-ENDORPHIN IN ALZHEIMERS-DISEASE. (1986) ARCHIVES OF GENERAL PSYCHIATRY 0003-990X 2168-6238 43 4 382-388
LANDGRAF R. PLASMA OXYTOCIN CONCENTRATIONS IN MAN AFTER DIFFERENT ROUTES OF ADMINISTRATION OF SYNTHETIC OXYTOCIN. (1985) EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY 0232-7384 85 2 245-248
EISENHOFER G et al. NO IMPROVEMENT IN ETHANOL-INDUCED MEMORY DEFICITS AFTER ADMINISTRATION OF A VASOPRESSIN ANALOG. (1985) LIFE SCIENCES 0024-3205 37 26 2499-2505
RAVID R et al. IMMUNOCYTOCHEMICAL LOCALIZATION OF VASOPRESSIN-BINDING SITES IN THE RAT-KIDNEY. (1985) JOURNAL OF ENDOCRINOLOGY 0022-0795 1479-6805 105 1 p. 133
STRUPP BJ et al. A MNEMONIC ROLE FOR VASOPRESSIN - THE EVIDENCE FOR AND AGAINST. (1985) NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 0149-7634 1873-7528 9 3 399-411
JENNEKENSSCHINKEL A et al. A CLINICAL-TRIAL WITH DEGLYCINAMIDE ARGININE VASOPRESSIN FOR THE TREATMENT OF MEMORY DISORDERS IN MAN. (1985) PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 0278-5846 1878-4216 9 3 273-284
ETTENBERG A. INTRACEREBROVENTRICULAR APPLICATION OF A VASOPRESSIN ANTAGONIST PEPTIDE PREVENTS THE BEHAVIORAL ACTIONS OF VASOPRESSIN. (1984) BEHAVIOURAL BRAIN RESEARCH 0166-4328 1872-7549 14 3 201-211
LACZI F et al. LACK OF EFFECT OF "DESGLYCINAMIDE-ARGININE-VASOPRESSIN (DGAVP) ON MEMORY IN PATIENTS WITH KORSAKOFFS SYNDROME. (1983) ACTA ENDOCRINOLOGICA 0001-5598 104 2 177-182,
2423510
Caballeria Elsa et al. A systematic review of treatments for alcohol-related cognitive impairment: lessons from the past and gaps for future interventions. (2020) PSYCHOLOGICAL MEDICINE 0033-2917 1469-8978 50 13 2113-2127
Leng Gareth et al. The vasopressin-memory hypothesis: a citation network analysis of a debate. (2019) ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 0077-8923 1749-6632 1455 1 126-140
Horton Lindsay et al. Interventions for alcohol-related brain damage (ARBD): Do specific approaches restrict the evolution of comprehensive patient care?. (2014) DRUGS: EDUCATION PREVENTION AND POLICY 0968-7637 1465-3370 21 5 408-419
BRAMBILLA F et al. NEUROPEPTIDE THERAPIES IN CHRONIC-SCHIZOPHRENIA - TRH AND VASOPRESSIN ADMINISTRATION. (1986) NEUROPSYCHOBIOLOGY 0302-282X 15 3-4 114-121
GASPAR L et al. The effects of oral clonidine on the growth hormone levels in acromegalic patients. (1984) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 7 4 327-329,
1375195
Samuels ER et al. Modulation of the acoustic startle response by the level of arousal: Comparison of clonidine and modafinil in healthy volunteers. (2007) NEUROPSYCHOPHARMACOLOGY 0893-133X 1470-634X 32 11 2405-2421
MULLER EE et al. INVOLVEMENT OF BRAIN CATECHOLAMINES AND ACETYLCHOLINE IN GROWTH-HORMONE HYPERSECRETORY STATES - PATHOPHYSIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS. (1995) DRUGS 0012-6667 50 5 805-837
RUTTEMAN GR et al. MEDROXY-PROGESTERONE ACETATE ADMINISTRATION TO OVARIOHYSTERECTOMIZED, ESTRADIOL-PRIMED BEAGLE BITCHES - EFFECT ON SECRETION OF GROWTH-HORMONE, PROLACTIN AND CORTISOL. (1987) ACTA ENDOCRINOLOGICA 0001-5598 114 2 275-282
GANZETTI I et al. FEEDBACK EFFECT OF GROWTH-HORMONE ON HYPOTHALAMIC OPIOID AND SOMATOCRININ PRODUCING NEURONS. (1987) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 0391-4097 1720-8386 10 3 241-246
Galfi M et al. Functional membrane changes due to tumor induction in rat pituitary cell cultures. (2000) JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH 0392-9078 1756-9966 19 4 531-535,
1791849
Sawisky GR et al. Intracellular calcium involvement in pituitary adenylate cyclase-activating polypeptide and gonadotrophin secretion stimulation of growth hormone in goldfish pituitary cells. (2005) JOURNAL OF NEUROENDOCRINOLOGY 0953-8194 1365-2826 17 6 353-371
Kajta M et al. Effects of estrone on quisqualate-induced toxicity in primary cultures of rat cortical neurons. (2005) JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 0867-5910 1899-1505 56 2 233-245